THMC Mental Health & Innovation Service
ADHD and Dementia Assessment
緻安精神健康醫療創新服務
Mental Health Service Specializing
in ADHD and Mood Disorders
for Children and Adults
Open as Usual on Saturday Afternoons
Multi-Protein Screening Blood Tests
for Alzheimer’s disease
THMC Mental Health & Innovation Service offers Multi-Protein Screening Blood Tests that detect Beta-amyloid and tau protein. Alzheimer’s disease is the most common form of dementia, accounting for approximately 60-70% of all dementia cases. Beta-amyloid and tau proteins accumulate in the brain of people with Alzheimer’s Disease 15 to 20 years before clinical symptoms of dementia. Our specialist in psychiatry will interpret the Multi-Protein Blood Test results with clinical assessment, cognitive assessment, as well as innovative and objective screening tests, including infrared brain scan and eye tracker test, to inform the client of the risk of Alzheimer’s disease and dementia. For high-risk group, they can go for further assessment tests including MRI and PET scan.
Existing Alzheimer’s medications are most effective at the early stage, and our clinic offers oral and intravenous treatment for dementia and Alzheimer’s disease.
Multi-Protein Screening Blood Tests
for Alzheimer’s disease
THMC Mental Health & Innovation Service offers Multi-Protein Screening Blood Tests that detect Beta-amyloid and tau protein. Alzheimer’s disease is the most common form of dementia, accounting for approximately 60-70% of all dementia cases. Beta-amyloid and tau proteins accumulate in the brain of people with Alzheimer’s Disease 15 to 20 years before clinical symptoms of dementia. Our specialist in psychiatry will interpret the Multi-Protein Blood Test results with clinical assessment, cognitive assessment, as well as innovative and objective screening tests, including infrared brain scan and eye tracker test, to inform the client of the risk of Alzheimer’s disease and dementia. For high-risk group, they can go for further assessment tests including MRI and PET scan.
Existing Alzheimer’s medications are most effective at the early stage, and our clinic offers oral and intravenous treatment for dementia and Alzheimer’s disease.
Multi-Protein Screening Blood Tests
for Alzheimer’s disease
THMC Mental Health & Innovation Service offers Multi-Protein Screening Blood Tests that detect Beta-amyloid and tau protein. Alzheimer’s disease is the most common form of dementia, accounting for approximately 60-70% of all dementia cases. Beta-amyloid and tau proteins accumulate in the brain of people with Alzheimer’s Disease 15 to 20 years before clinical symptoms of dementia. Our specialist in psychiatry will interpret the Multi-Protein Blood Test results with clinical assessment, cognitive assessment, as well as innovative and objective screening tests, including infrared brain scan and eye tracker test, to inform the client of the risk of Alzheimer’s disease and dementia. For high-risk group, they can go for further assessment tests including MRI and PET scan.
Existing Alzheimer’s medications are most effective at the early stage, and our clinic offers oral and intravenous treatment for dementia and Alzheimer’s disease.
The Eye Tracking System
(Oculomotricity)
The eye tracker monitors attention during different eye movement tasks and can assess an individual whether his or her performance is in a disease range (e.g., ADHD or Alzheimer’s disease) or a normal range.
The device used in this clinic is a Class IIa CE medical device that fulfills conformity assessment under the European Union's Medical Device Regulation (MDR).
Driven by Precision
Defined by Results
Brain Wellness Check
fNIRS + qEEG + specific questionnaire
For HKD$9,600
Whatsapp for more information
